Breast cancer terminal - Nursing Case Study

Pathophysiology

• Primary mechanism: Breast cancer terminally progresses through the uncontrolled proliferation of malignant cells originating from breast tissue, often driven by genetic mutations such as BRCA1 or BRCA2, leading to tumor growth and metastasis.

• Secondary mechanism: Angiogenesis, the formation of new blood vessels, supports tumor survival and expansion by supplying essential nutrients and oxygen, facilitating further metastatic spread to distant organs like the lungs, liver, bones, and brain.

• Key complication: Metastatic spread results in organ dysfunction and failure, significantly impacting patient prognosis and quality of life, often leading to severe symptoms and complications that require complex palliative care.

Patient Profile

Demographics:

54-year-old female, retired school teacher

History:

• Key past medical history: Diagnosed with stage III breast cancer two years ago, underwent mastectomy and chemotherapy; family history of breast cancer (mother)

• Current medications: Tamoxifen, Lisinopril, Metformin, Oxycodone for pain management

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Worsening fatigue and shortness of breath

• Key symptoms: Persistent cough, chest pain, weight loss, night sweats, increasing pain in the spine

• Vital signs: Blood pressure 140/90 mmHg, heart rate 110 beats per minute, respiratory rate 26 breaths per minute, temperature 37.8°C, oxygen saturation 88% on room air

Section 1

In this stage of the case study, we focus on new diagnostic results that contribute to the understanding of the patient's condition. Upon admission, a series of diagnostic tests were conducted to evaluate the extent of disease progression and identify any new complications. A chest X-ray and CT scan of the thorax revealed multiple pulmonary nodules, consistent with metastatic spread to the lungs. Additionally, there was evidence of pleural effusion, which is contributing to the patient's shortness of breath and hypoxemia. A bone scan showed increased uptake in the thoracic and lumbar spine, indicating possible metastatic lesions, correlating with the patient's increasing spinal pain.

Laboratory tests further delineated the patient's worsening condition. Blood tests demonstrated a mild anemia with a hemoglobin level of 10.2 g/dL, potentially contributing to her fatigue. Elevated calcium levels were noted at 11.5 mg/dL, suggesting possible hypercalcemia of malignancy, which can lead to symptoms such as fatigue, nausea, and confusion. Liver function tests indicated mild hepatic dysfunction, with elevated alkaline phosphatase and transaminases, suggesting hepatic involvement, though further imaging would be necessary to confirm liver metastases.

These diagnostic results indicate a progression of the disease with significant metastasis, necessitating adjustments in her management plan. The findings provide a clear path for clinical reasoning, highlighting the need for interventions aimed at managing symptoms and complications. The presence of pleural effusion and potential spinal metastases call for multidisciplinary involvement, including thoracic and orthopedic consultations, to address the patient's respiratory distress and skeletal pain. The hypercalcemia requires prompt intervention with hydration and bisphosphonates to prevent further metabolic derangement. This stage sets the groundwork for subsequent discussions on palliative care options and potential treatments to improve quality of life.

Section 2

Change in Patient Status:

In the days following the initial diagnostic results, the patient's condition has shown further decline, necessitating ongoing monitoring and adjustment of the care plan. Her respiratory status has become more compromised, with increasing dyspnea at rest. Vital signs reveal tachypnea with a respiratory rate of 28 breaths per minute and an oxygen saturation of 88% on room air, prompting the need for supplemental oxygen therapy. Additionally, her blood pressure is noted at 98/60 mmHg, which, coupled with her tachycardia at 112 beats per minute, could indicate a compensatory response to hypoxemia or dehydration secondary to hypercalcemia.

The patient's pain has escalated, particularly in the thoracic and lumbar regions, correlating with the metastatic lesions identified on her bone scan. She rates her pain as 8/10 on the numeric pain scale despite previously optimized analgesic therapy. This increased pain level is affecting her ability to mobilize, contributing to her overall fatigue and decreased functional status. The need for a more aggressive pain management regimen, possibly including the addition of adjuvant medications such as corticosteroids or nerve blocks, is evident to improve her comfort and quality of life.

Furthermore, the patient has developed new-onset confusion and lethargy, raising concerns for worsening hypercalcemia or possible hepatic encephalopathy given her abnormal liver function tests. A repeat serum calcium level now measures at 12.3 mg/dL, confirming the need for urgent intervention to mitigate the risk of further neurological deterioration. This progression highlights the importance of a coordinated approach involving endocrinology for hypercalcemia management, palliative care for symptom control, and ongoing evaluation of the need for additional resources to support both the patient and her family in this challenging phase of her illness.

Section 3

In response to the urgent need to address the patient's escalating symptoms, the healthcare team initiated several targeted interventions. Supplemental oxygen therapy was commenced, starting with 2 liters per minute via nasal cannula, to improve her oxygen saturation levels. Given her persistent hypoxemia, the flow was titrated up to maintain an oxygen saturation of at least 92%. Concurrently, intravenous fluids were administered to address potential dehydration contributing to her hypotension and tachycardia, while also assisting in the management of hypercalcemia. This was complemented by the administration of bisphosphonates to reduce serum calcium levels more effectively.

Despite these interventions, the patient exhibited minimal improvement in her respiratory and neurological status. Follow-up laboratory tests revealed a slight reduction in serum calcium to 11.8 mg/dL, yet her confusion and lethargy persisted, indicating the need for further diagnostic evaluation. A chest X-ray was ordered to rule out any underlying pulmonary complications such as pleural effusion or atelectasis that could exacerbate her dyspnea. Meanwhile, her pain management regimen was adjusted to include a low-dose corticosteroid, aiming to reduce inflammation around metastatic lesions and provide additional analgesia.

The healthcare team remains vigilant, closely monitoring the patient's vital signs and neurological status. A multidisciplinary meeting was convened to reassess the care plan, focusing on optimizing symptom control and improving her quality of life. The team discussed the potential benefits of palliative radiation therapy to target the painful bone metastases and considered consulting neurology to further investigate her altered mental status. These steps aim to preempt new complications, ensuring that the patient's journey continues with dignity and as much comfort as possible.

Section 4

New Complications:

As the team continued to manage the patient's complex symptomatology, new complications began to surface. The chest X-ray revealed a moderate right-sided pleural effusion, which was likely contributing to her ongoing respiratory distress. This finding prompted the decision to perform a therapeutic thoracentesis to alleviate her dyspnea, with the expectation that removing the excess fluid would improve her lung expansion and oxygenation. The procedure was scheduled for the following day, with careful consideration of her overall frailty and the need to minimize procedural risks.

In conjunction with the respiratory challenges, the patient's neurological status continued to deteriorate. The neurology consult revealed evidence of possible brain metastases, as the patient's MRI showed multiple small lesions consistent with metastatic disease. This discovery explained her persistent confusion and lethargy and presented a new layer of complexity to her care. The healthcare team faced the difficult decision of weighing the potential benefits and burdens of further interventions, such as whole-brain radiation, given her terminal status and current quality of life.

The emergence of these complications required a recalibration of the care plan, focusing on the patient's comfort and goals of care. Discussions with the patient and her family reaffirmed the emphasis on palliative measures, prioritizing symptom relief and emotional support. The healthcare team, now more than ever, was committed to providing holistic and compassionate care as the patient navigated this challenging phase of her illness. This evolving situation underscored the importance of ongoing assessment, vigilant monitoring, and adaptive clinical reasoning to address her needs effectively.

Section 5

As the day of the scheduled thoracentesis arrived, the patient's condition warranted a reassessment to ensure her stability for the procedure. During the morning assessment, her vital signs showed a temperature of 99.1°F, heart rate of 102 beats per minute, respiratory rate of 24 breaths per minute, blood pressure of 95/60 mmHg, and oxygen saturation fluctuating between 88-91% on 2L of supplemental oxygen. Her respiratory distress had slightly worsened overnight, and she was notably more tachypneic and using accessory muscles to breathe. Auscultation of the chest revealed diminished breath sounds on the right side, consistent with the previously identified pleural effusion, and scattered wheezes bilaterally.

Laboratory results from the morning blood draw indicated a hemoglobin level of 9.1 g/dL, reflecting mild anemia, and an elevated white blood cell count of 13,500/mm³, suggesting a possible inflammatory process. Her electrolyte panel showed a sodium level of 133 mmol/L and potassium level of 4.2 mmol/L, with slight hyponatremia being an expected finding given her current nutritional intake and overall frailty. The combination of these findings necessitated a careful consideration of the potential risks and benefits of proceeding with thoracentesis, as well as a thorough discussion with the patient and family regarding the anticipated outcomes and potential complications.

The healthcare team, acknowledging the patient's frailty and complex clinical picture, deliberated on the best course of action. They considered the possibility of postponing the thoracentesis in favor of optimizing her respiratory support and addressing her electrolyte imbalance and potential infection. Ultimately, the decision was made to proceed with the procedure, with enhanced monitoring and support measures in place. This decision highlighted the importance of dynamic clinical reasoning and the need to balance interventional benefits with the overarching goal of maintaining the patient's comfort and dignity in her terminal phase. The unfolding situation required the healthcare team to remain adaptable, ensuring all interventions aligned with the patient's goals of care and her family's expectations.